drugset / Trial / NCT00405535

Adjunctive Glycine for Obsessive Compulsive Disorder

NCT00405535 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether individuals with obsessive compulsive disorder who will take a preparation of the amino acid glycine in addition to their current treatment, may experience improvement in their symptoms.

Timeline

Start
2004-06
Primary completion
—
Completion
2006-12

Outcome

Missed primary endpoint

paper not quite reaching statistical significance (p=0.053). PMID 19046587 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Glycine Other / unclassified 60 g Oral